Skip to main content
Log in

Expression of monoamine oxidase B activity in astrocytes of senile plaques

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

Monoamine oxidase (MAO) histochemistry has been performed in brains from patients with dementia of Alzheimer type (DAT) and aged controls. Conspicuous MAO-positive cell clusters were frequently observed in the amygdala, hippocampus, and insular cortex in the brains of DAT. Double staining with glial fibrillary acidic protein immunohistochemistry revealed that the clusterforming MAO-positive cells were astrocytes. Using Bielschowsky's method, Congo red and thioflavin S counterstaining, this astrocytic mass was shown to be associated with senile plaques. By the enzyme inhibition experiment, MAO activity in senile plaques was revealed to be of type B. The present results clearly indicate that MAO-B activity is expressed in fibrillary astrocytes in or around senile plaques, suggesting that these astrocytes metabolize exogenous amines in senile plaques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adolfsson R, Gottfries C-G, Oreland L, Wiberg Å, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27:1029–1034

    Google Scholar 

  2. Arai R, Kimura H, Maeda T (1986) Topographic atlas of monoamine oxidase-containing neurons in the rat brain studied by an improved histochemical method. Neuroscience 19:905–925

    Google Scholar 

  3. Beach TG, Tago H, Nagai T, Kimura H, McGeer PL, McGeer EG (1987) Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation. J Neurosci Methods 19:183–192

    Google Scholar 

  4. Chiba K, Trevor A, Castagnoli N Jr (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120: 574–578

    Google Scholar 

  5. Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK Perry RH, Blessed G, Tomlinson BE (1983) Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci 60:383–392

    Google Scholar 

  6. Fowler CJ (1982) Selective inhibitors of MAO types A and B and their clinical usefulness. Drugs Future 7:501–517

    Google Scholar 

  7. Fowler CJ, Tipton KF (1984) On the substrate specific of the two forms of monoamine oxidase. J Pharm Pharmacol 36:111–115

    Google Scholar 

  8. Fowler CJ, Oreland L, Marcusson J, Winblad B (1980) Titration of human brain monoamine oxidase-A and -B by clorgyline and l-deprenyl. Naunyn-Schmiedeberg's Arch Pharmacol 311: 263–272

    Google Scholar 

  9. Fowler CJ, Wiberg Å, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49:1–20

    Google Scholar 

  10. Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, Christman D, Logan J, Smith M, Sachs H, Aquilonius SM, Bjurling P, Halldin C, Hartvig P, Leenders KL, Lundqvist H, Oreland L, Stålnacke C-G, Långström B, (1987) Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivatiors and PET. Science 235:481–485

    Google Scholar 

  11. Garrick NA, Murphy DL (1980) Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 72:27–33

    Google Scholar 

  12. Glover V, Sandler M, Owen F, Riley GJ (1977) Dopamine is a monoamine oxidase B substrate in man. Nature 265:80–81

    Google Scholar 

  13. Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC (1984) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311:467–469

    Google Scholar 

  14. Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285–1297

    Google Scholar 

  15. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (1988) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144

    Google Scholar 

  16. Kishimoto S, Kimura H, Maeda T (1983) Histochemical demonstration for monamine oxidase (MAO) by a new coupled peroxidation method. Cell Mol Biol 29:61–69

    Google Scholar 

  17. Kitahama K, Sakai K, Tago H, Kimura H, Maeda T, Jouvett M (1984) Monoamine oxidase-containing neurons in the cat hypothalamus: distribution and ascending projection to the cerebral cortex. Brain Res 324:155–159

    Google Scholar 

  18. Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393–408

    Google Scholar 

  19. Konradi C, Svoma E, Jellinger K, Riederer P, Denney R, Thibault J (1988) Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem. Neuroscience 26:791–802

    Google Scholar 

  20. Mann JJ, Stanley M (1984) Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr Scand 69:135–139

    Google Scholar 

  21. O'Carroll A-M, Fowler CJ, Phillips JP, Tobbia I, Tipton KF (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn-Schmiedeberg's Arch Pharmacol 322:198–202

    Google Scholar 

  22. Oreland L, Gottfries C-G (1986) Brain and brain monoamine oxidase in aging and dementia of Alzheimer's type. Prog Neuro-Psychopharmacol Biol Psychiatry 10:533–540

    Google Scholar 

  23. Reinikainen KJ, Paljärvi L, Halonen T, Malminen O, Kosma V-M, Laakso M, Riekkinen PJ (1988) Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 9:245–252

    Google Scholar 

  24. Riederer P, Jellinger K (1983) Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline). Acta Neurol Scand [Suppl] 95:43–55

    Google Scholar 

  25. Reiderer P, Youdim MBH, Rausch WD, Brikmayer W, Jellinger K, Seemann D (1978) On the mode of action of l-deprenyl in the human central nervous system. J Neural Transm 43:217–226

    Google Scholar 

  26. Riederer P, Konradi C, Shay V, Kienzl E, Birkmayer G, Danielczyk W, Sofic E, Youdim MBH (1986) Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of l-deprenyl. Adv Neurol 45:111–118

    Google Scholar 

  27. Squires RF (1972) Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. Adv Biochem Psychopharmacol 5:355–370

    Google Scholar 

  28. Tago H, Kimura H, Kitahama K, Sakai K, Jouvet M, Maeda T (1984) Cortical projections of monoamine oxidase-containing neurons from the posterior hypothalamus in the rat. Neurosci Lett 52:281–286

    Google Scholar 

  29. Westlund KN, Denney RM, Kochersperger LM, Rose RM, Abell CW (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230:181–183

    Google Scholar 

  30. Westlund KN, Denney RM, Rose RM, Abell CW (1988) Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neuroscience 25:439–456

    Google Scholar 

  31. Yates CM, Allison Y, Simpson J, Maloney AFJ, Gordon A (1979) Dopamine in Alzheimer's disease and senile dementia. Lancet II:851–852

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, S., Kawamata, T., Akiguchi, I. et al. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 80, 419–425 (1990). https://doi.org/10.1007/BF00307697

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00307697

Key words

Navigation